Thank you for sharing!

Your article was successfully shared with the contacts you provided.
The drug was recently approved by the FDA advisory committee, but has remained controversial. (Photo: Shutterstock)

An opioid painkiller that is ten times more powerful than a drug linked to an epidemic of overdose deaths has been approved by the Food and Drug Administration (FDA)—despite the recommendation of an advisory committee’s chairman to reject the drug.


Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now

Copyright © 2018 ALM Media Properties, LLC. All Rights Reserved.